Riskpilot← Back to searchSign inGet full accessSALIXIN A/S
A/SActiveCVR 33776748Gammel Vråvej 31Manufacture of pharmaceutical preparations · NACE 2120Est. 20111 employees
Revenue 2024
DKK -346K
+21% vs 2023
EBITDA margin
172.5%
+93% vs 2023
Equity ratio
2.6%
Financial strength
Net profit 2024
DKK 1,1M
+112% vs 2023
| Revenue | DKK -346K | +21% |
| EBITDA | DKK -596K | +93% |
| Net profit | DKK 1,1M | +112% |
| Total assets | DKK 711K | -65% |
| Equity | DKK 18K | +102% |
| Employees | 1 | — |
Legal name
SALIXIN A/S
CVR number
33776748
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. juli 2011
Share capital
DKK 780.388
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsesformanden, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med kosmetiske behandlinger, udvikling, markedsføring, og omsætning af helse- og kosmetikmidler samt hermed beslægtet virksomhed efter bestyrelsens skøn.
Address
Gammel Vråvej 31
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -151 | -26 | 197 | 123 | 475 | -417 | -235 | -5 | 70 | 9.103 | 496 | -286 | -346 |
| Staff expenses | -264 | -258 | -253 | -75 | -34 | -250 | -862 | -924 | -878 | -720 | -156 | -0 | -0 |
| EBITDA | -592 | -428 | -152 | -110 | 190 | -667 | -1.097 | -929 | -808 | 8.383 | 341 | -8.960 | -596 |
| Depreciation & amort. | 180 | 120 | 120 | 122 | -65 | -66 | -72 | -80 | -85 | -90 | -91 | -250 | -41 |
| EBIT | -772 | -548 | -272 | -232 | 125 | -733 | -1.169 | -1.009 | -893 | 8.294 | 250 | -9.210 | -638 |
| Net financials | -34 | -70 | -57 | -69 | -73 | -71 | -79 | -137 | -144 | -163 | -179 | -8.875 | 1.666 |
| Profit before tax | -806 | -619 | -329 | -301 | 52 | -804 | -1.248 | -1.146 | -1.037 | 8.130 | 71 | -9.411 | 1.029 |
| Tax | -201 | -131 | -59 | -60 | 12 | -177 | -275 | -257 | -291 | 1.786 | 16 | -877 | -23 |
| Net profit | -605 | -487 | -270 | -240 | 41 | -627 | -974 | -889 | -746 | 6.345 | 55 | -8.534 | 1.052 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 930 | 904 | 1.056 | 1.231 | 1.659 | 1.697 | 2.168 | 2.506 | 2.334 | 9.825 | 9.810 | 2.004 | 711 |
| Equity | 395 | -93 | -363 | -603 | 37 | 160 | -814 | -1.703 | -2.449 | 3.895 | 3.950 | -1.033 | 18 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 1.095 | 1.854 | 2.385 | 2.480 | 2.320 | 2.317 | 613 |
| Short-term debt | 535 | 997 | 1.419 | 1.834 | 1.622 | 1.537 | 1.887 | 2.355 | 2.398 | 2.566 | 2.641 | 721 | 80 |
| Total debt | 535 | 997 | 1.419 | 1.834 | 1.622 | 1.537 | 2.982 | 4.209 | 4.783 | 5.047 | 4.961 | 3.037 | 693 |
EBITDA margin
-59616200.0%
This company
15.8%
Market median
-377317822% vs market
20122024
Equity ratio
2.6%
This company
38.2%
Market median
-93% vs market
20122024
Return on equity
5788.2%
This company
18.4%
Market median
+31358% vs market
20122024
Net profit margin
105165900.0%
This company
8.1%
Market median
+1298344344% vs market
20122024
Asset turnover
-0.49×
This company
1.12×
Market median
-144% vs market
20122024
Debt / equity
38.14×
This company
0.62×
Market median
-6052% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SF Management | Management | 2011 | — | — |
HL Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ny Vraa A/S | Company | 100.0% | 100.0% | 2024 |
MICHAEL BUNDGAARD HOLDING ApS | Company | 33.3% | 33.3% | 2022 |
LB 2021 Holding ApS | Company | 20.0% | 20.0% | 2023 |
Ydesen Holding ApS | Company | 20.0% | 20.0% | 2022 |
Trinitas Invest A/S | Company | 10.0% | 10.0% | 2017 |
SØREN FISKER ApS | Company | 20.0% | 20.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AB 2021 Holding ApS
SALIXIN A/S Board members of SALIXIN A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Fisker | Management | 0 companies |
| Henrik Lyngsø Bach | Management | 0 companies |
| Louise Bech | Board of Directors | 0 companies |
| Andreas Ydesen | Chairman | 0 companies |
| Anders Lyngsø Bach | Board of Directors | 0 companies |
| Aage Bay Bach | Board of Directors | 0 companies |
| Allan Juul Bech | Chairman | 0 companies |
| Tabitha Enevold Bundgaard | Board of Directors | 0 companies |
| Peter Christoffersen | Chairman | 0 companies |
| Michael Bundgaard | Chairman | 0 companies |